{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:42:11Z","timestamp":1782949331742,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ajo.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:49:23Z","timestamp":1754927363000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Association Between Circularity of Neovascular Lesion and Polypoidal Lesion Regression in Polypoidal Choroidal Vasculopathy"],"prefix":"10.1016","volume":"280","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2144-3989","authenticated-orcid":false,"given":"Jaehwan","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5282-7793","authenticated-orcid":false,"given":"Kiyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-5178","authenticated-orcid":false,"given":"Seung-Young","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2025.08.007_bib0001","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2025.08.007_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajo.2025.08.007_bib0003","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-pacific ocular imaging society PCV workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.08.007_bib0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OPTH.S385827","article-title":"Polypoidal choroidal vasculopathy: an update on diagnosis and treatment","volume":"17","author":"Sen","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.08.007_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ajo.2020.05.017","article-title":"A comparison study of polypoidal choroidal vasculopathy imaged with indocyanine green angiography and swept-source optical coherence tomography angiography","volume":"217","author":"Kim","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.08.007_bib0006","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.oret.2023.11.001","article-title":"Polypoidal choroidal vasculopathy: evaluation based on 3-dimensional reconstruction of OCT angiography","volume":"8","author":"Teo","year":"2024","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ajo.2025.08.007_bib0007","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41598-024-52448-y","article-title":"Effect of polyp regression and reduction on treatment efficacy in polypoidal choroidal vasculopathy treated with aflibercept","volume":"14","author":"Sayanagi","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajo.2025.08.007_bib0008","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12886-023-03264-x","article-title":"Seven-year outcomes of combined treatment of anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy; according to polypoidal lesion regression","volume":"23","author":"Lee","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.08.007_bib0009","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00417-020-04977-1","article-title":"The polyp regression rate and treatment prognosis of different interventions for polypoidal choroidal vasculopathy: a systematic review and meta-analysis","volume":"259","author":"Zhao","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.08.007_bib0010","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00417-017-3718-6","article-title":"Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy","volume":"255","author":"Morimoto","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.08.007_bib0011","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/ph17060687","article-title":"Association of polyp regression after loading phase with 12-month outcomes of eyes with polypoidal choroidal vasculopathy","volume":"17","author":"Kimura","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.ajo.2025.08.007_bib0012","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/IAE.0000000000002384","article-title":"Posttreatment polyp regression and risk of massive submacular hemorrhage in eyes with polypoidal choroidal vasculopathy","volume":"40","author":"Cho","year":"2020","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ajo.2025.08.007_bib0013","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"issue":"15","key":"10.1016\/j.ajo.2025.08.007_bib0014","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.62.15.5","article-title":"Choroidal changes in eyes with polypoidal choroidal vasculopathy after Anti-VEGF therapy imaged with swept-source OCT angiography","volume":"62","author":"Shen","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.08.007_bib0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00417-016-3507-7","article-title":"A modified treat-and-extend regimen of aflibercept for treatment-na\u00efve patients with neovascular age-related macular degeneration","volume":"255","author":"Ohnaka","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2025.08.007_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/srep21090","article-title":"Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2025.08.007_bib0017","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.oret.2019.09.012","article-title":"Age-related changes in choroidal thickness and the volume of vessels and stroma using swept-source OCT and fully automated algorithms","volume":"4","author":"Zhou","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2025.08.007_bib0018","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1364\/BOE.9.006067","article-title":"Attenuation correction assisted automatic segmentation for assessing choroidal thickness and vasculature with swept-source OCT","volume":"9","author":"Zhou","year":"2018","journal-title":"Biomed Opt Express"},{"issue":"7","key":"10.1016\/j.ajo.2025.08.007_bib0019","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.08.007_bib0020","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41598-024-52747-4","article-title":"One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients","volume":"14","author":"Inoda","year":"2024","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ajo.2025.08.007_bib0021","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/IAE.0000000000002760","article-title":"Diagnostic characteristics of polypoidal choroidal vasculopathy based on B-scan swept-source optical coherence tomography angiography and its interrater agreement compared with indocyanine green angiography","volume":"40","author":"Fujita","year":"2020","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2025.08.007_bib0022","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/IAE.0000000000001702","article-title":"Polypoidal choroidal vasculopathy upon optical coherence tomographic angiography","volume":"38","author":"Chan","year":"2018","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2025.08.007_bib0023","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamaophthalmol.2019.0449","article-title":"Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography","volume":"137","author":"Bo","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.08.007_bib0024","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/IAE.0000000000001628","article-title":"Biomarkers of neovascular activity in age-related macular degeneration using optical coherenece tomography angiography","volume":"38","author":"Al-Sheikh","year":"2018","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2025.08.007_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/IAE.0000000000002807","article-title":"Quantitative optical coherence tomography angiography features of inactive macular neovascularization in age-related macular degeneration","volume":"41","author":"Serra","year":"2021","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2025.08.007_bib0026","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/IAE.0000000000003439","article-title":"Polypoidal choroidal neovascularization versus type 1 choroidal neovascularization in age-related macular degeneration: a fractal analysis study","volume":"42","author":"Serra","year":"2022","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2025.08.007_bib0027","article-title":"Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ajo.2025.08.007_bib0028","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41433-024-03253-4","article-title":"Pachychoroid Disease: Review and Update","volume":"39","author":"Cheung","year":"2025","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.ajo.2025.08.007_bib0029","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bjophthalmol-2021-319090","article-title":"Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK","volume":"106","author":"Ogura","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.08.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62559-1","article-title":"One-year outcomes and safety assessment of faricimab in treatment-na\u00efve patients with neovascular age-related macular degeneration in Japan","volume":"14","author":"Mukai","year":"2024","journal-title":"Sci Rep"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425004131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425004131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:13:59Z","timestamp":1779855239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425004131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"alternative-id":["S0002939425004131"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.08.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Circularity of Neovascular Lesion and Polypoidal Lesion Regression in Polypoidal Choroidal Vasculopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}